Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works by Guan-Qiao Li
Results: 6
1
2
Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes.
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1103949
- By:
- Publication type:
- Article
3
Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer.
- Published in:
- Expert Review of Molecular Diagnostics, 2024, v. 24, n. 1/2, p. 99, doi. 10.1080/14737159.2024.2301940
- By:
- Publication type:
- Article
4
Impact of the 21-gene recurrence score testing on chemotherapy selection and clinical outcomes in T3N0 luminal breast cancer.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 12, p. 1283, doi. 10.1080/14737140.2024.2423683
- By:
- Publication type:
- Article
5
Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer.
- Published in:
- BJS Open, 2022, v. 6, n. 2, p. 1, doi. 10.1093/bjsopen/zrac025
- By:
- Publication type:
- Article